BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25980655)

  • 21. The Inhibitory Effect of Curcumin on Hypoxia Inducer Factors (Hifs) as a Regulatory Factor in the Growth of Tumor Cells in Breast Cancer Stem-Like Cells.
    Sarighieh MA; Montazeri V; Shadboorestan A; Ghahremani MH; Ostad SN
    Drug Res (Stuttg); 2020 Nov; 70(11):512-518. PubMed ID: 32961574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
    Choi YH; Yoo YH
    Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells.
    Tsai SC; Huang WW; Huang WC; Lu CC; Chiang JH; Peng SF; Chung JG; Lin YH; Hsu YM; Amagaya S; Yang JS
    Int J Oncol; 2012 Dec; 41(6):2065-72. PubMed ID: 23008020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells.
    Kim JA; Kim DH; Hossain MA; Kim MY; Sung B; Yoon JH; Suh H; Jeong TC; Chung HY; Kim ND
    Int J Oncol; 2014 Feb; 44(2):473-80. PubMed ID: 24316714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of apoptosis and G2/M arrest by ampelopsin E from Dryobalanops towards triple negative breast cancer cells, MDA-MB-231.
    Rahman NA; Yazan LS; Wibowo A; Ahmat N; Foo JB; Tor YS; Yeap SK; Razali ZA; Ong YS; Fakurazi S
    BMC Complement Altern Med; 2016 Sep; 16(1):354. PubMed ID: 27609190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen‑ and doxorubicin‑induced autophagy.
    Yenigun VB; Ozpolat B; Kose GT
    Int J Mol Med; 2013 Jun; 31(6):1477-83. PubMed ID: 23589132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mahanine, A dietary phytochemical, represses mammary tumor burden in rat and inhibits subtype regardless breast cancer progression through suppressing self-renewal of breast cancer stem cells.
    Das M; Kandimalla R; Gogoi B; Dutta KN; Choudhury P; Devi R; Dutta PP; Talukdar NC; Samanta SK
    Pharmacol Res; 2019 Aug; 146():104330. PubMed ID: 31251988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells.
    Wang S; Mou Z; Ma Y; Li J; Li J; Ji X; Wu K; Li L; Lu W; Zhou T
    Biochem Pharmacol; 2015 May; 95(2):98-109. PubMed ID: 25824241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of acetylation and bundling of cellular microtubules by 9-(4-vinylphenyl) noscapine elicits S-phase arrest in MDA-MB-231 cells.
    Cheriyamundath S; Mahaddalkar T; Kantevari S; Lopus M
    Biomed Pharmacother; 2017 Feb; 86():74-80. PubMed ID: 27939522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavior-selective apoptotic capacity of 4-(3,4,5-Trimethoxyphenoxy) benzoic acid and its methyl derivatives on two breast cancer cell lines.
    Lee KH; Ho WY; Wu SJ; Cheng TL; Huang PJ; Wang CC; Hung JH
    Anticancer Res; 2014 Apr; 34(4):1801-9. PubMed ID: 24692713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy.
    Han YK; Lee JH; Park GY; Chun SH; Han JY; Kim SD; Lee J; Lee CW; Yang K; Lee CG
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1329-33. PubMed ID: 23261434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
    Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
    Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.
    Jeong H; Kim J; Lee Y; Seo JH; Hong SR; Kim A
    Oncol Rep; 2014 Sep; 32(3):1218-24. PubMed ID: 25018110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of Sulfonamide Moiety into Biguanide Scaffold Results in Apoptosis Induction and Cell Cycle Arrest in MCF-7 Breast Cancer Cells.
    Markowicz-Piasecka M; Sadowski K; Huttunen J; Sikora J; Huttunen KM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro.
    Yang ZR; Liu M; Peng XL; Lei XF; Zhang JX; Dong WG
    Biochem Biophys Res Commun; 2012 May; 421(3):627-33. PubMed ID: 22546556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ; Rosengren RJ
    Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231.
    Kim JB; Lee KM; Ko E; Han W; Lee JE; Shin I; Bae JY; Kim S; Noh DY
    Planta Med; 2008 Jan; 74(1):39-42. PubMed ID: 18203057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.